Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on XGT062 05. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114075201A reveals a novel 2-step route for Sitagliptin Impurity XGT062-05. Achieve high purity via Cope elimination, ensuring reliable API intermediate supply.